AMBALAL SARABHAI ENT L Share Price

AMBALAL SARABHAI ENT L Share Price

NSE: AMBALALSA
|
Pharmaceuticals

₹ 38.50

-₹0.25 (-0.65%)
1D
Last updated 13 Oct, 2026, 15:29 IST

AMBALAL SARABHAI ENT L Share Price Today

As of 14 Oct 2026, AMBALAL SARABHAI ENT L share price is ₹38.50. The stock opened at ₹38.75, compared to its previous close of ₹38.75. During today's trading session, AMBALAL SARABHAI ENT L share price moved in the range of ₹38.30 to ₹38.94, with an average price of ₹38.62 for the day. Looking at its last 52-week, the stock has touched a low of ₹30.15 and a high of ₹49.98. On the performance front, AMBALAL SARABHAI ENT L share price has increased by 8.99% over the last six months and is up 8.99% on a year-on-year basis.

₹38.30
0.65% down today
₹38.94
1D LOW
1D HIGH

AMBALAL SARABHAI ENT L Returns Calculator

Volume
45,122
Average traded price
₹38.62
Last traded time
03:29:38 13 Oct
Last traded quantity
500
Circuit
L
H
₹36.82
₹40.68
52-week
L
H
₹30.15
₹49.98
Mkt Cap Cr
299.02
P/E
21.86
P/B
1.87
ROA
4.82%
ROE
11.24%
ROCE
10.51%
Quick Ratio
1.04
EV/EBITDA
14.08
Based on fundamentals, this stock's
Step 4 of 5
Performance
Good
Ambalal Sarabhai outperforming most market indices
Step 1 of 5
Valuation
Overvalued
Ambalal Sarabhai appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Ambalal Sarabhai earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0134.835.0511.19%13.74%17.33%2.3121.42
Divis Laboratories2,48,982.9885.1214.8514.6%15.32%19.56%3.556.28
Torrent Pharmaceuticals1,76,300.5082.5521.164.87%25.49%13.85%0.7538.11
Zydus Lifesciences1,13,615.6924.744.198.57%18.59%17.35%0.9114.87
Laurus Labs1,11,898.66102.6321.1110.38%16.77%16.14%0.6853.86
Cipla1,06,129.9631.623.087.92%11.27%14.95%2.517.83
Dr. Reddy's Laboratories1,02,707.4132.262.75.48%11.07%12.54%1.3515.86
Mankind Pharma99,089.5247.926.087.36%11.74%13.13%0.7425.7
Aurobindo Pharma97,972.4726.42.596.34%9.25%11.76%1.1512.47
Lupin89,628.8316.033.9614.47%23.76%24.88%1.429.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About AMBALAL SARABHAI ENT L

AMBALAL SARABHAI ENT L Share Price
ISIN
INE432A01017
Sector Market Cap
₹ 299.02 Cr

Ambalal Sarabhai Enterprises Limited is an India-based company that is engaged in the business of manufacturing pharmaceuticals and electronics. The Company's segments include Pharmaceuticals and Electronics. Asence Inc., a wholly owned subsidiary of the Company, specializes in the supply of pharmaceutical preparations (finished dosage forms and active pharmaceutical ingredients) to the international markets. Its subsidiary, Sarabhai Chemicals (India) Private Limited, offers products in the oncology, infertility and Uro-gynaec areas. Its wholly owned subsidiary, Suvik Hitek Pvt. Ltd., is engaged in manufacturing pharmaceutical products and marketing generics and veterinary products in the domestic market. Its subsidiary, Systronics (India) Limited, is a manufacturer of analytical and test and measuring instruments, distributing its products across India. Its other subsidiaries include Synbiotics Limited, Asence Pharma Private Limited, and Sarabhai M Chemicals Limited, among others.

AMBALAL SARABHAI ENT L Financial Highlights

  • Revenue: AMBALAL SARABHAI ENT L reported revenue of ₹217.44 crore in FY26 vs ₹207.57 crore in FY25. It showed an increase of 4.76% on a yearly basis.
  • Operating Profit: AMBALAL SARABHAI ENT L reported an operating profit of ₹18.51 crore in FY26 vs ₹4.83 crore in FY25. It showed an increase of 283.23% on a year-on-year basis.
  • Net Profit: AMBALAL SARABHAI ENT L reported a net profit of ₹17.80 crore in FY26 vs ₹4.93 crore in FY25. It showed an increase of 261.05% on a yearly basis.

AMBALAL SARABHAI ENT L Quarterly Result Highlights

  • AMBALAL SARABHAI ENT L reported revenue of ₹45.59 crore in Jun 2026, compared with ₹68.10 crore in Mar 2026, representing a decrease of 33.05% on a quarter-on-quarter (QoQ) basis.
  • AMBALAL SARABHAI ENT L reported an operating profit of ₹4.68 crore in Jun 2026, compared with ₹6.25 crore in Mar 2026, representing a decrease of 25.12% on a quarter-on-quarter (QoQ) basis.
  • AMBALAL SARABHAI ENT L reported a profit of ₹3.98 crore in Jun 2026, compared with ₹6.50 crore in Mar 2026, reflecting a decrease of 38.77% on a QoQ basis.
  • The earnings per share (EPS) of AMBALAL SARABHAI ENT L stood at ₹2.32 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
31.36%
FII
0.00%
Other DII
0.01%
Retail and other
68.63%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.34%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%
1 day
-0.85%
1 week
-0.34%
1 month
-4.74%
1 year
+8.99%
3 years
+8.99%
5 years
+8.99%
Day
Open / Close
Change %
13 Oct 26
₹38.75 / ₹38.50
-0.65%
12 Oct 26
₹40.49 / ₹38.75
-4.53%
09 Oct 26
₹41.08 / ₹40.59
+0.79%
08 Oct 26
₹40.47 / ₹40.27
-0.49%
Show more

AMBALAL SARABHAI ENT L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2023Mar 2024Mar 2025Mar 2026
Revenue182.77183.94207.57217.44
Operating profit15.176.654.8318.51
Net profit11.455.684.9317.8

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹18.51₹4.83₹6.65₹15.17
Income before WC changes₹15.60₹7.03₹11.12₹14.57
Change in Assets₹2.87-₹38.35₹0.42-₹0.96
Change in Liabilities-₹5.55₹16.91₹1.35-₹3.48
Change in WC-₹2.68-₹21.43₹1.77-₹4.43
Cash flow from Operations₹13.40-₹17.62₹8.89₹5.72
Cash flow from Investing-₹10.25₹13.26-₹5.30-₹16.78
Cash flow from Financing-₹1.85-₹1.52-₹2.95₹9.09
Total Cash Flow₹1.30-₹5.88₹0.65-₹1.97
Cash (Start of the year)₹4.89₹10.78₹10.13₹12.10
Cash (End of the year)₹6.19₹4.89₹10.78₹10.13

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹156.10₹153.08₹130.98₹134.80
Current Assets₹125.03₹118.59₹118.54₹110.94
Total Assets₹281.13₹271.68₹249.52₹245.74
Current Liabilities₹98.54₹120.51₹102.32₹102.87
Net Current Asset₹26.49-₹1.92₹16.23₹8.07
Non-Current Liabilities₹24.22₹11.18₹10.78₹11.94
Equity Capital₹158.36₹139.98₹136.42₹130.93
Total Equity & Liabilities₹281.13₹271.68₹249.52₹245.74

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹3.94₹4.04₹3.81₹3.71
Other Income₹15.57₹15.29₹7.89₹10.53
Total Revenue₹19.52₹19.33₹11.70₹14.24
Total Expenses₹9.57₹11.81₹10.89₹9.12
Profit Before Tax₹9.95₹8.08₹0.81₹4.34
Tax-₹1.04-₹0.16-₹1.77₹0.23
Profit After Tax₹10.99₹8.24₹2.58₹4.11
EPS - Basic₹1.43₹1.08₹0.34₹0.54
EPS - Diluted₹1.43₹1.08₹0.34₹0.54

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹9.95₹8.08₹0.81₹4.34
Income before WC changes₹0.20-₹6.15-₹3.16-₹1.37
Change in Assets-₹0.42₹2.33-₹1.91₹2.70
Change in Liabilities-₹2.88₹0.38₹1.93₹0.98
Change in WC-₹3.30₹2.71₹0.02₹3.68
Cash flow from Operations-₹0.26-₹4.08-₹3.82₹1.52
Cash flow from Investing-₹3.02₹6.35₹3.48₹0.61
Cash flow from Financing₹3.40-₹2.31₹0.30-₹3.76
Total Cash Flow₹0.11-₹0.04-₹0.04-₹1.63
Cash (Start of the year)₹0.08₹0.13₹0.17₹1.80
Cash (End of the year)₹0.20₹0.08₹0.13₹0.17

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹44.09₹44.30₹44.79₹45.35
Current Assets₹41.71₹38.62₹36.49₹34.40
Total Assets₹85.79₹82.92₹81.28₹79.74
Current Liabilities₹23.14₹34.12₹40.65₹41.49
Net Current Asset₹18.56₹4.50-₹4.16-₹7.09
Non-Current Liabilities₹3.17₹0.30₹0.34₹0.41
Equity Capital₹59.48₹48.49₹40.29₹37.85
Total Equity & Liabilities₹85.79₹82.92₹81.28₹79.74
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
43.4
Neutral
ATR (14)
2
Neutral
STOCH(9,6)
33.96
Neutral
STOCH RSI (14)
30.95
Neutral
ADX(9)
12.26
Bullish
UO(9)
50.24
Neutral
ROC(12)
-6.71
Bearish
WillR(14)
-70.73
Neutral
Period
Simple value
Exponential vaue
5D
39.73
39.54
10D
39.24
39.58
20D
39.63
40
50D
42.08
39.84
100D
37.3
40.9
Volume trend — traded volume by day
13 Oct0L
12 Oct0L
9 Oct0L
8 Oct0L
7 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
AMBALAL SARABHAI ENT L Share Price
AMBALAL SARABHAI ENT L
Pharmaceuticals
Add Stock
Add Another

AMBALAL SARABHAI ENT L Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.